跳至主要内容
临床试验/NCT04456179
NCT04456179已完成不适用

Evaluation of Sensifree's PPG Based Continuous & Non-Invasive Blood Pressure Monitoring System in Comparison to Invasive Radial Arterial Line

Sensifree Ltd.2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2020年2月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
6
试验地点
2
主要终点
Evaluation of the magnitude of blood pressure change (measured in mmHg) cause by different isometric efforts in humans

研究概览

简要总结

The purpose of this study is to evaluate methods to modify blood pressure in humans and measure the effectiveness of such methods. A secondary outcome is to evaluate the performance of an investigational continuous non-invasive blood pressure (cNIBP) device created by Sensifree. The tests will per performed in non-hospitalized subjects under varied controlled conditions that include resting blood pressure and non-pharmacologically induced blood pressure changes.

详细描述

On a first visit a screening procedure to verify inclusion / exclusion criteria are met will be conducted. On the primary procedure visit, data collection will begin with the subjects having the investigational device, ECG sensors, and 1 or more pulse oximetry sensors placed on them for data collection and to monitor their safety for the duration of the study. A physician will place an arterial line in the radial artery. The Sensifree cNIBP system will be calibrated with an oscillometric and/or auscultatory blood pressure cuff measurement taken on the arm opposite the arterial line.

A series of blood pressure changes will be induced, including various combinations of methods.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject must have the ability to understand and provide written informed consent
  • Subject must be willing and able to comply with study procedures and duration

排除标准

  • Subject with a BMI over 39
  • Deformities or abnormalities that may prevent proper application of the device under test
  • Lateral difference in blood pressure greater than 5mmHg diastolic and 9mmHg systolic
  • Tachycardia or resting heart rate less than 45 bpm
  • Females who are pregnant, who are trying to get pregnant, (confirmed by positive urine pregnancy test unless the subject is known to be not of child-bearing potential)
  • Subjects with known respiratory conditions such as: (self-reported)
  • uncontrolled / severe asthma,
  • pneumonia / bronchitis,
  • shortness of breath / respiratory distress,
  • respiratory or lung surgery,
  • emphysema, COPD, lung disease
  • Subjects with known heart or cardiovascular conditions such as: (self-reported, except for blood pressure and ECG review)
  • have had cardiovascular surgery
  • have cardiac pacemakers and/or automatic internal cardio-defibrillator
  • Chest pain (angina)
  • Abnormal pulse pressure
  • previous heart attack
  • blocked artery
  • unexplained shortness of breath
  • congestive heart failure (CHF)
  • history of stroke
  • transient ischemic attack
  • carotid artery disease
  • myocardial ischemia
  • myocardial infarction
  • cardiomyopathy
  • Pulsus Paradoxus
  • Self-reported health conditions as identified in the Health Assessment Form (self-reported)
  • diabetes,
  • uncontrolled thyroid disease,
  • kidney disease / chronic renal impairment,
  • history of seizures (except childhood febrile seizures),
  • epilepsy,
  • history of unexplained syncope,
  • recent history of frequent migraine headaches,
  • recent head injury
  • cancer / chemotherapy
  • Subjects with known clotting disorders (self-reported)
  • history of bleeding disorders or personal history of prolonged bleeding from injury
  • history of blood clots
  • hemophilia
  • current use of blood thinner: prescription or daily use of aspirin
  • Subjects with severe contact allergies to standard adhesives, latex or other materials found in pulse oximetry sensors, ECG electrodes, respiration monitor electrodes or other medical sensors (self-reported)
  • Subjects with a contact allergy to ultrasound gel.
  • Subjects with prior or known allergies to iodine or lidocaine (or similar pharmacological agents, e.g. Novocaine)
  • Failure of the Perfusion Index Ulnar/Ulnar+Radial Ratio test
  • Subject is intoxicated during the time of the visit, or was intoxicated within 24 hours prior to study visit, as reported by the subject, or per study staff judgment.
  • Other known health condition, should be considered upon disclosure in health assessment form

结局指标

主要结局

Evaluation of the magnitude of blood pressure change (measured in mmHg) cause by different isometric efforts in humans

时间窗: 3-4 hours per subject

Measure the effect of a combination of the following isometric efforts on a subject's blood pressure (measured in mmHg): 1. Hand grip 2. Weight lifting 3. Leg static effort

次要结局

  • Measure the accuracy of an investigational continuous non-invasive blood pressure (cNIBP) device(3-4 hours per subject)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验